MIST
Milestone Pharmaceuticals
$0.76
+$0.07 (+9.55%)Oct 28, 2026
Key metrics
The numbers that frame MIST today
- Market cap
- $94.24M
- Gross margin
- 98%
- EV / Sales
- 28.3
- ROIC
- -53.9%
- Div yield
- 0%
- Debt / equity
- 7.8
- 52wk Low
- $0.63
- 52wk High
- $3.06
Growth
Revenue and earnings trend for MIST
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MIST
Is Milestone Pharmaceuticals a good buy?
No. Milestone Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Milestone Pharmaceuticals is selling at a very high price.
What is the market capitalization of MIST?
Milestone Pharmaceuticals's market capitalization is $94.24M.
What is the 52-week high for MIST stock?
The 52-week high for Milestone Pharmaceuticals is $3.06. The current close of $0.76 is 75.3% below that high.
What is the 52-week low for MIST stock?
The 52-week low for Milestone Pharmaceuticals is $0.63. The current close of $0.76 is 20% above that low.
Does MIST stock pay dividends?
Milestone Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MIST?
Milestone Pharmaceuticals's Debt / Equity ratio is 7.79.